The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
Torben Redmer(German Cancer Research Center), Christian Regenbrecht(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 99
Related Papers
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
|PLoS Genetics|2019|81
The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
|Oncogenesis|2017|65
CD271 determines migratory properties of melanoma cells
|Scientific Reports|2017|44
Decoding molecular programs in melanoma brain metastases
|medRxiv|2022|1